Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

SCOTTSDALE, Ariz., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent) announced that it has partnered with ATI to invest more than $50 million over the next several years in ATI's Nitinol melt and materials conversion infrastructure. With this significant investment, which will more than triple ATI's melt capacity for medical Nitinol, Confluent will become ATI's fulfillment partner and provide a suite of value-add services and order-fulfillment for ATI medical Nitinol mill product. ...